THNR

Amplify Weight Loss Drug & Treatment ETF

THNR | AMEX
$25.95
+$0.59 (+2.35%)
At close: Oct 30, 2026, 3:59 PM ET
$25.86
-$0.09 (-0.35%)
After-hours: Oct 30, 2026, 5:10 PM ET
+2.35%

No price chart data available for 1D timeframe.

Key Statistics

Market Cap 5.97M
AVG Volume 7.36K
AUM 4.2M
NAV 24.73
1D Range
25.75 26.07
52W Range
23.15 27.91

About THNR

THNR provides access to global companies expected to economically benefit from weight loss drug development. THNR seeks investment results that generally correspond to the performance (before fees and...

Asset Class Equity
Holdings 20
Inception Date May 21, 2024
Expense Ratio 0.59%
Domicile United States
ISIN US0321085328

Top Sectors

Sector Weight
Healthcare 99.55%
Financial Services 0.25%
Cash & Others 0.20%

Top Holdings

45.47% of assets
Name Symbol Weight
Novo Nordisk A/s NVO 14.55%
Eli Lilly & Co LLY 13.40%
Amgen Inc AMGN 6.05%
Arrowhead Pharmaceut... ARWR 5.86%
Regeneron Pharmaceut... REGN 5.61%

Dividends

Yield 1.59%
Ex-Div Amount Pay Date
Dec 30, 25 $0.4132 Dec 31, 25
Dec 30, 24 $0.2199 Dec 31, 24

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.